NOVN: A Banner Year for Novan – 2021 Results
By John Vandermosten, CFA
NASDAQ:NOVN
READ THE FULL NOVN RESEARCH REPORT
VYNE Reports Preclinical Data For Lead BET Inhibitor, VYN201, In Human Skin Model Of Vitiligo
VYNE Therapeutics Inc. (NASDAQ:VYNE) (“VYNE” or the “Company”), a biopharmaceutical company focused on developing proprietary, innovative, and differentiated therapies for the treatment of
VYNE Therapeutics Announces Phase 1b Data For FMX114 from Phase 1b/2a Trial For Treatment Of Mild-To-Moderate Atopic Dermatitis
VYNE Therapeutics Inc. (NASDAQ:VYNE) ("VYNE" or the "Company") today announced that it has completed the Phase 1b portion of a Phase 1b/2a clinical trial evaluating FMX114 for the treatment of
52 Biggest Movers From Friday
Gainers
Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its TapouT performance drink in Walmart stores across Florida metropolitan areas.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Avinger (NASDAQ:AVGR) stock moved upwards by 9.7% to $0.34 during Friday's after-market session. This security traded at a volume of 1.2 million shares come close, making up 60.0% of its average volume over the last 100 days. The company's market cap stands at $32.6 million.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
48 Biggest Movers From Yesterday
Gainers
Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday.
MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58.
